chr4-119150976-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_016599.5(MYOZ2):c.181C>T(p.Arg61Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000211 in 1,612,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_016599.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYOZ2 | NM_016599.5 | c.181C>T | p.Arg61Cys | missense_variant | Exon 3 of 6 | ENST00000307128.6 | NP_057683.1 | |
MYOZ2 | XM_006714234.5 | c.181C>T | p.Arg61Cys | missense_variant | Exon 3 of 6 | XP_006714297.1 | ||
LOC105379404 | XR_001741421.2 | n.-17G>A | upstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151970Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251286Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135796
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1460926Hom.: 0 Cov.: 33 AF XY: 0.0000275 AC XY: 20AN XY: 726856
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151970Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74188
ClinVar
Submissions by phenotype
not provided Uncertain:2
A variant of uncertain significance has been identified in the MYOZ2 gene. The R61C variant has not been publishedas a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant was not observedin approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome SequencingProject, indicating it is not a common benign variant in these populations. The R61C variant is a non-conservativeamino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity,charge, size and/or other properties. This substitution occurs at a position that is conserved across species and insilico analysis predicts this variant is probably damaging to the protein structure/function. However, no missensevariants in nearby residues have been reported in the Human Gene Mutation Database (Stenson et al., 2014).Furthermore, this variant has been previously observed in one other unrelated individual referred for cardiomyopathygenetic testing at GeneDx who also harbored a pathogenic variant in a mitochondrial gene associated withcardiomyopathy.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or benign. -
- -
Hypertrophic cardiomyopathy Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 61 of the MYOZ2 protein (p.Arg61Cys). This variant is present in population databases (rs755233280, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with MYOZ2-related conditions. ClinVar contains an entry for this variant (Variation ID: 213656). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MYOZ2 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.R61C variant (also known as c.181C>T), located in coding exon 2 of the MYOZ2 gene, results from a C to T substitution at nucleotide position 181. The arginine at codon 61 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Hypertrophic cardiomyopathy 16 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at